Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SFINX: Sugammadex and postoperative alertness after general anesthesia
2011-000157-23Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2011
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Sugammadex in neuromuscular block (NMB), sponsored by Radboud University Medical Center. Primary endpoint: Postoperative alertness and psychomotor recovery over time. Started Jan 2011; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular block (NMB)
Beyond the preview
Go deeper on 2011-000157-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000157-23.